China Medical System Partners with Insilico on AI Drug Discovery, Gains Trial Approval
Feb 13, 2026
China Medical System Holdings partnered with Insilico Medicine on AI-powered drug discovery in early February 2026 and received Chinese regulatory approval to begin human trials for complement factor B inhibitor CMS-D017.